SMARCA4 and leukoencephalopathy with calcifications and cysts: Further analysis showed that SMARCA4 mutations (p=0.13, Figure 3A), but not KEAP1 mutations (p=0.64, Figure 3B) remained associated with poor survival within the LCC subgroup.